glp 1 and general anesthesia The Impact of GLP-1 Receptor Agonists on Sedation Bariatric Surgery vs. GLP-1 Drugs

however, the precise mechanisms remain unclear

J Pharm Sci 100:40744089 Kapitza C, Nosek L, Jensen L, Hartvig H, Jensen CB, Flint A (2015) Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

The two drugs are FDA-approved for the treatment of type 2 diabetes and for weight loss

they did not reply to our attempts to work with them on getting the information out to primary and secondary care

This dual-effect paradigm underscores the importance of evaluating TMAOs impact in the context of dose, duration, and pathophysiological background

Salaffi F et al